CLINICAL_TRIALS
trial_result
· 2013-06-07
Clinical Trial Update: Fibroblast Growth Factor-23 (FGF23) Reduction in Predialysis Chronic Kidney Disease (CKD) [NA]
Summary
A clinical trial update reports the completion of a study evaluating reduction of fibroblast growth factor-23 in predialysis chronic kidney disease. Results wer…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Myles Wolf | Conditions: Kidney Disease | NA | Status: COMPLETED | Results posted: 2013-06-07